| (JPY) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 9.70B | — |
| Operating expense | — | — |
| Net income | -1.91B | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, 4552.T returned -12.9% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -24.9% |
| 1 year | -12.9% |
| 5 years | -80.1% |
| 10 years | -11.2% |
| All-time high | ¥3,740 (Jun 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what ¥1,000 in 4552.T would be worth today ›Yes. JCR Pharmaceuticals Co., Ltd. paid 2 dividends over the past 12 months. The most recent was ¥10 per share on Mar 30, 2026. The dividend yield is 3.80%.
JCR Pharmaceuticals Co., Ltd. is part of the Healthcare sector.
JCR Pharmaceuticals Co., Ltd. has a market cap of 63.45B JPY, based on the latest quote.
JCR Pharmaceuticals Co., Ltd. is expected to report earnings around Oct 29, 2026. That date is an estimate and has not been confirmed by the company.
